|
| 达嘉维康(301126)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-12-09 | 8187.02 | 39.65% | 19159.39 | 1491.18 | 10881.92 | 52.70% | 首发原股东限售股份 | | 2022-12-07 | 5674.28 | 27.48% | 10836.92 | 9813.65 | 10836.92 | 52.48% | 首发原股东限售股份 | | 2022-06-07 | 266.25 | 1.29% | 5162.64 | 15487.93 | 5162.64 | 25.00% | 首发机构配售股份 | | 2021-12-07 | 4896.39 | 23.71% | 4896.39 | 15754.18 | 4896.39 | 23.71% | 首发一般股份 |
|